Toward specific cardiac IK1 modulators for in vivo application: Old drugs point the way

Heart Rhythm

Volumn 8, Issue 7, 2011, Pages 1076-1080

  Van Der Heyden, Marcel A G ^a   Sánchez Chapula, José A ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSIDAD DE COLIMA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC INWARD RECTIFIER CURRENT I K1; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; ION CHANNEL; UNCLASSIFIED DRUG;

HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; ION CURRENT; PRIORITY JOURNAL; REVIEW;

EID: 79959984679     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2011.01.038     Document Type: Article

References (68)

1. Roden DM, George AL Jr. The cardiac ion channels: relevance to management of arrhythmias. Annu Rev Med 1996;47:135-148. (Pubitemid 26138879)
2. Roden DM, Balser JR, George AL Jr, Anderson ME. Cardiac ion channels. Annu Rev Physiol 2002;64:431-475. (Pubitemid 34259236)
3. K1) controls cardiac excitability and is involved in arrhythmogenesis. Heart Rhythm 2005;2:316-324.
4. Preisig-Müller R, Schlichthörl G, Goerge T, et al. Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome. Proc Natl Acad Sci U S A 2002;99:7774-7779. (Pubitemid 34568767)
5. Schram G, Pourrier M, Melnyk P, Nattel S. Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function. Circ Res 2002;90:939-950. (Pubitemid 34633859)
6. Wang Z, Yue L, White M, Pelletier G, Nattel S. Differential distribution of inward rectifier potassium channel transcripts in human atrium versus ventricle. Circulation 1998;98:2422-2428. (Pubitemid 28549786)
7. Ehrlich JR, Cha TJ, Zhang L et al. Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties. J Physiol 2003;551:801-813. (Pubitemid 37221074)
8. K1 up-regulation in human atrial fibrillation. Heart Rhythm 2009;6:1802-1809.
9. Voigt N, Trausch A, Knaut M, et al. Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3:472-480.
10. IR2.x inward rectifier ion channel family: expression pattern and pathophysiology. Acta Physiol (Oxf) 2010;199:243-255.
11. Anumonwo JMB, Lopatin AN. Cardiac strong inward rectifier potassium channels. J Mol Cell Cardiol 2010;48:45-54.
12. K1) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes. J Physiol 2001;533:697-710.
13. Miake J, Marbán E, Nuss HB. Biological pacemaker created by gene transfer. Nature 2002;419:132-133. (Pubitemid 35025436)
14. K1) in the mouse heart accelerates and stabilizes rotors. J Physiol 2007;578:315-326.
15. Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, Kurachi Y. Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol Rev 2010;90:291-366.
16. Robertson JL, Palmer LG, Roux B. Long-pore electrostatics in inward-rectifier potassium channels. J Gen Physiol 2008;132:613-632.
17. Tai K, Stansfeld PJ, Sansom MSP. Ion-blocking sites of the Kir2.1 channel revealed by multiscale modeling. Biochemistry 2009;48:8758-8763.
18. + channels and scorpion toxins. Trends Pharmacol Sci 2003;24:222-227.
19. Pegan S, Arrabit C, Zhou W, et al. Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification. Nat Neurosci 2005;8:279-287. (Pubitemid 40300184)
20. Kurata HT, Cheng WW, Arrabit C, Slesinger PA, Nichols CG. The role of the cytoplasmic pore in inward rectification of Kir2.1 channels. J Gen Physiol 2007;130:145-155. (Pubitemid 47204906)
21. Shin HG, Xu Y, Lu Z. Evidence for sequential ion-binding loci along the inner pore of the IRK1 inward-rectifier K+ channel. J Gen Physiol 2005;126:123-135. (Pubitemid 41124189)
22. Fujiwara Y, Kubo Y. Functional roles of charged amino acid residues on the wall of the cytoplasmic pore of KIR2.1. J Gen Physiol 2006;127:401-419.
23. + current acting as pure class III antiarrhythmic agents. J Cardiovasc Pharmacol 1992;20 Suppl. 2:S106-S113.
24. + channels by chlorpromazine in rat ventricular myocytes. J Pharmacol Exp Ther 1994;271:632-637.
25. Carnes CA, Muir WW 3rd, Van Wagoner DR. Effect of intravenous anesthetics on inward rectifier potassium current in rat and human ventricular myocytes. Anesthesiology 1997;87:327-334. (Pubitemid 27435375)
26. + channels by chloroethylclonidine. Br J Pharmacol 1999;128:760-766.
27. Sánchez-Chapula JA, Salinas-Stefanon E, Torres-Jácome J, Benavides-Haro DE, Navarro-Polanco RA. Blockade of currents by the antimalarial drug chloroquine in feline ventricular myocytes. J Pharmacol Exp Ther 2001;297:437-445. (Pubitemid 32242605)
28. K, and HERG channels of cardiac myocytes. Acta Pharmacol Sin 2001;22:125-131.
29. + currents in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 2003;285:H661-668.
30. Sun H, Liu X, Xiong Q, Shikano S, Li M. Chronic inhibition of cardiac Kir2.1 and HERG potassium channels by celastrol with dual effects on both ion conductivity and protein trafficking. J Biol Chem 2006;281:5877-5884. (Pubitemid 43847688)
31. IR2.x-mediated inward rectifier current by entering the cytoplasmic pore region of the channel. Br J Pharmacol 2010;159:1532-1541.
32. Caballero R, Dolz-Gaitón P, Gómez R. et al. Flecainide increases Kir2.1 currents by interacting with cysteine 311, decreasing the polyamine-induced rectification. Proc Natl Acad Sci U S A 2010;107:15631-15636.
33. + 2.x family of inward rectifier channels by interfering with phosphatidylinositol 4,5-bisphosphate-channel interactions. J Pharmacol Exp Ther 2009;331:563-573.
34. López-Izquierdo A, Ponce-Balbuena D, Ferrer T, Rodríguez-Menchaca AA, Sánchez-Chapula JA. Thiopental inhibits function of different inward rectifying potassium channel isoforms by a similar mechanism. Eur J Pharmacol 2010;638:33-41.
35. Rodríguez-Menchaca AA, Navarro-Polanco RA, Ferrer-Villada T, et al. The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel. Proc Natl Acad Sci U S A 2008;105:1364-1368. (Pubitemid 351397059)
36. Noujaim SF, Stuckey JA, Ponce-Balbuena D, et al. Specific residues of the cytoplasmic domains of cardiac inward rectifier potassium channels are effective antifibrillatory targets. FASEB J 2010;24:4302-4312.
37. Jansen JA, De Boer TP, Wolswinkel R, et al. Lysosome mediated Kir2.1 breakdown directly influences inward rectifier current density. Biochem Biophys Res Commun 2008;367:687-692.
38. Kuryshev YA, Ficker E, Wang L, et al. Pentamidine-induced long QT syndrome and block of hERG trafficking. J Pharmacol Exp Ther 2005;312:316-323. (Pubitemid 40096484)
39. v11.1. Eur J Pharmacol 2011;652:96-103.
40. Wang Z, Fermini B, Nattel S. Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes. J Pharmacol Exp Ther 1995;272:184-196.
41. Yue L, Feng JL, Wang Z, Nattel S. Effects of ambasilide, quinidine, flecainide and verapamil on ultra-rapid delayed rectifier potassium currents in canine atrial myocytes. Cardiovasc Res 2000;46:151-161. (Pubitemid 30155955)
42. Ramos E, O'Leary ME. State-dependent trapping of flecainide in the cardiac sodium channel. J Physiol 2004;560:37-49. (Pubitemid 39406015)
43. Watanabe H, Chopra N, Laver D. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med 2009;15:380-383.
44. Sridhar A, Nishijima Y, Terentyev D, et al. Chronic heart failure and the substrate for atrial fibrillation. Cardiovasc Res 2009;84:227-236.
45. Rose J, Armoundas AA, Tian Y, et al. Molecular correlates of altered expression of potassium currents in failing rabbit myocardium. Am J Physiol Heart Circ Physiol 2005;288:H2077-2087.
46. Soltysinska E, Olesen, Christ T, et al. Transmural expression of ion channels and transporters in human nondiseased and end-stage failing hearts. Pflugers Arch 2009;459:11-23.
47. Dobrev D, Wettwer E, Kortner A, Knaut M, Schüler S, Ravens U. Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res 2002;54:397-404. (Pubitemid 34327918)
48. Gaborit N, Steenman M, Lamirault G, et al. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation 2005;112:471-481. (Pubitemid 41060786)
49. Tsuji Y, Opthof T, Yasui K, et al. Ionic mechanisms of acquired QT prolongation and Torsade de pointes in rabbits with chronic complete atrioventricular block. Circulation 2002;106:2012-2018. (Pubitemid 35176310)
50. Ehrlich JR. Inward rectifier potassium currents as a target for atrial fibrillation therapy. J Cardiovasc Pharmacol 2008;52:129-135.
51. Sánchez-Chapula J. Increase in action potential duration and inhibition of the delayed rectifier outward current IK by berberine in cat ventricular myocytes. Br J Pharmacol 1996;117:1427-1434. (Pubitemid 26116767)
52. Xu SZ, Zhang Y, Ren JY, Zhou ZN. Effects of berberine of L- and T-type calcium channels in guinea pig ventricular myocytes. Zhongguo Yao Li Xue Bao 1997;18:515-518. (Pubitemid 27473886)
53. Kr of guinea pig cardiomyocytes by chlorpromazine. J Cardiovasc Pharmacol 2004;43:706-714.
54. Kim KS, Kim EJ. The phenothiazine drugs inhibit hERG potassium channels. Drug Chem Toxicol 2005;28:303-313.
55. Thomas D, Wu K, Kathöfer S, et al. The antipsychotic drug chlorpromazine inhibits HERG potassium channels. Br J Pharmacol 2003;139:567-574. (Pubitemid 36819626)
56. Ogata N, Narahashi T. Block of sodium channels by psychotropic drugs in single guinea-pig cardiac myocytes. Br J Pharmacol 1989;97:905-913. (Pubitemid 19168726)
57. + channels by RP58866. Br J Pharmacol 1999;127:1899-1907.
58. Brandts B, Van Bracht M, Tüttelmann F, Allessie MA, Trappe HJ. Inhibition of muscarinic potassium current by the class III antiarrhythmic drug RP58866 in guinea-pig atrial myocytes. Pacing Clin Electrophysiol 2000;23:1812-1815.
59. + currents in mammalian ventricular myocytes. Zhongguo Yao Li Xue Bao 1999;20:961-969.
60. + currents in part by interfering with phosphatidylinositol 4,5-bisphosphate-channel interaction. J Pharmacol Sci 2010;113:66-75.
61. Kr, in rabbit ventricular myocytes. J Pharmacol Exp Ther. 1998;287:877-883.
62. + currents in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 2003;285:H661-668.
63. 2+ transient in single atrial cells from guinea pig. Pharmacology 2007;80:33-39.
64. Ks in guinea-pig isolated ventricular myocytes. Exp Physiol 1996;81:587-603.
65. Martynyuk AE, Morey TE, Raatikainen MJ, Seubert CN, Dennis DM. Ionic mechanisms mediating the differential effects of methohexital and thiopental on action potential duration in guinea pig and rabbit isolated ventricular myocytes. Anesthesiology 1999;90:156-164.
66. + current changes account for the rate dependence of the action potential in the human atrial myocyte. Am J Physiol Heart Circ Physiol 2009;297:1398-1410.
67. Ten Tusscher KH, Noble D, Noble PJ, Panfilov AV. A model for human ventricular tissue. Am J Physiol Heart Circ Physiol 2004;286:1573-1589.
68. El Harchi A, McPate MJ, Zhang Y, Zhang H, Hancox JC. Action potential clamp and chloroquine sensitivity of mutant Kir2.1 channels responsible for variant 3 short QT syndrome. J Mol Cell Cardiol 2009;47:743-747.